CompletedPhase 2NCT02311673
Phase 2 Trial to Evaluate Safety and Efficacy of Setmelanotide (RM-493) in Obese Participants With Prader-Willi Syndrome
Studying Prader-Willi syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Rhythm Pharmaceuticals, Inc.
- Principal Investigator
- David MeekerRhythm Pharmaceuticals, Inc.
- Intervention
- Setmelanotide(drug)
- Enrollment
- 40 enrolled
- Eligibility
- 16-65 years · All sexes
- Timeline
- 2015 – 2016
Study locations (5)
- University of California Irvine, Irvine, California, United States
- University of Florida, Gainesville, Florida, United States
- Kansas University Medical Center, Kansas City, Kansas, United States
- Winthrop University Hospital, Mineola, New York, United States
- Vanderbilt University, Nashville, Tennessee, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02311673 on ClinicalTrials.govOther trials for Prader-Willi syndrome
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07450664Observational Study of VYKAT™ XR in Patients With Prader-Willi SyndromeSoleno Therapeutics, Inc.
- ENROLLING BY INVITATIONPHASE3NCT07219485A Study of Pitolisant in Participants With Prader-Willi SyndromeHarmony Biosciences Management, Inc.
- RECRUITINGPHASE4NCT06901245Tirzepatide in PWS, HO and GNSOGrace Kim
- RECRUITINGNCT06877715Autistic Symptomatology and Sensory Profile in Children With Prader-Willi SyndromeUniversity Hospital, Toulouse
- ACTIVE NOT RECRUITINGPHASE2NCT06772597A Study of Setmelanotide in Patients With Prader-Willi SyndromeRhythm Pharmaceuticals, Inc.
- RECRUITINGPHASE3NCT06366464A Study of Pitolisant in Patients With Prader-Willi SyndromeHarmony Biosciences Management, Inc.
- ENROLLING BY INVITATIONPHASE3NCT06420297OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi SyndromeACADIA Pharmaceuticals Inc.
- ACTIVE NOT RECRUITINGPHASE3NCT06144645A Clinical Evaluation of Non-Invasive Vagus Nerve Stimulation for Temper Outbursts in People With PWSFoundation for Prader-Willi Research